Orchid Chemicals & Pharmaceuticals Ltd has informed BSE that the Allotment Committee of the Board of Directors of the Company at its meeting held on May 29, 2008 have allotted 16,375 equity shares of Rs 10 each as per particulars given below.
- 16,175 equity shares of Rs 10 each (16,150 equity shares at an adjusted […]

Orchid Chemicals & Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 29, 2008, to transact the following:
1. approve the audited financial results of the Company for the financial year ended March 31, 2008.
2. consider recommendation of dividend on equity capital for the […]

Orchid Chemicals & Pharmaceuticals Ltd has informed BSE that the Allotment Committee of the Board of Directors of Company at its meeting held on April 26, 2008 have allotted 9,425 equity share of Rs 10 each as per particulars given below:
- 7,525 equity shares of Rs 10 each (7,400 equity shares at an adjusted price […]

Orchid Chemicals & Pharmaceuticals Ltd has informed BSE that the Company and Ranbaxy Laboratories Ltd (Ranbaxy) on April 22, 2008 has announced that they have entered into a Business Alliance Agreement involving multiple geographies and therapies for both finished dosage formulations and active pharmaceutical ingredients. Additionally, this agreement would establish a framework for enhanced future […]

Orchid Chemicals & Pharmaceuticals Ltd has informed BSE that the Company is announcing, on April 10, 2008 the formation of its wholly owned subsidiary in Japan called Orchid Pharma Japan K K (Orchid Japan). Orchid Japan, is headquartered in Tokyo, will drive Orchid’s foray into the high potential and growing Japanese generics market.

In this regards […]

Orchid Chemicals & Pharmaceuticals Ltd has informed BSE regarding the Press Release dated March 18, 2008 titled “Orchid Chemicals clarifies on market fall of its shares”.
For further details please refer to the notice no 20080318-33 dated March 18, 2008.

Orchid Chemicals & Pharmaceuticals Ltd on February 08 2008 has announced that Dr. B Gopalan has been appointed as Chief Scientific Officer and Director of Orchid Research Laboratories Ltd, the wholly-owned subsidiary of the Company.